Tag

Tagged: degenerative disease

Sponsored
joined 10 years, 9 months ago

The London Neurosurgery Partnership is a unique concept in the provision of neurosurgical care. The team comprises eleven Consultant Neurosurgeons, all of whom are recognised superspecialists in their given area of expertise. As a result we can ensure that every patient seen by the group is matched with the Consultant Neurosurgeon best placed by virtue of their training and expertise to deliver the individualised and state of the art care each patient deserves.

Working as a team also ensures that our patients can access high quality neurosurgical care at all times from a consultant who will be familiar with their treatment plan at a location convenient to the patient. When appropriate, advice and treatment can be delivered by the composite team.

The London Neurosurgery Partnership has access to all of the latest neurosurgical technologies including the CyberKnife® and Gamma Knife® for radiosurgery which avoids the use of conventional open surgery in some cases and Minimally Invasive Techniques for both Cranial and Spinal neurosurgery when this is not possible. A key aspect of making use of such cutting edge technologies is the decision making process involved and this, in our opinion, is best done by a group of clinicians who are used to working together as a team to ensure that the latest technology and techniques are used appropriately based on the latest clinical guidelines.


view this profile

Parkinson’s disease is a progressive degenerative neurological movement disorder, which affects between six and 10 million people worldwide. In the US, the combined direct and indirect costs of Parkinson’s disease is estimated to be nearly US$25 billion per year. Medication costs for an individual person with Parkinson’s is on average US$2,500 a year and therapeutic surgery, such as deep brain stimulation, can cost up to US$100,000 dollars per patient.

view in full page